Shortsell.net [Beta]

Akari Therapeutics

AKTX

Akari Therapeutics has been a target of short sellers for a while. The current short interest of 1.55% is slightly below the average of the last 12 months (7.04%).

Short Interest Trend
Share Price
Total NSP
1.55%
-0.38%
vs. last month
Note: The short selling data for Akari Therapeutics may be distorted by a recent stock split!